Breaking News

China October Manufacturing PMI 50.8; Est. 51.2
Tweet TWEET

J&J Says Arbitration Panel Rejected Several Claims, Allegations

Johnson & Johnson said an arbitration panel rejected several claims and allegations by Basilea Pharmaceutica AG over the development of the antibiotic ceftobiprole. The panel found J&J breached its licensing agreement with Basilea, J&J said in an e-mailed statement. J&J said it couldn’t disclose further details.

To contact the reporter on this story: Elizabeth Lopatto in New York at elopatto@bloomberg.net

To contact the editor responsible for this story: Phil Serafino at pserafino@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.